Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Hypoxic vasodilatory defect and pulmonary hypertension in mice lacking hemoglobin β-cysteine93 S-nitrosylation
Rongli Zhang, Alfred Hausladen, Zhaoxia Qian, Xudong Liao, Richard T. Premont, Jonathan S. Stamler
Rongli Zhang, Alfred Hausladen, Zhaoxia Qian, Xudong Liao, Richard T. Premont, Jonathan S. Stamler
View: Text | PDF
Research Article Cardiology Vascular biology

Hypoxic vasodilatory defect and pulmonary hypertension in mice lacking hemoglobin β-cysteine93 S-nitrosylation

  • Text
  • PDF
Abstract

Systemic hypoxia is characterized by peripheral vasodilation and pulmonary vasoconstriction. However, the system-wide mechanism for signaling hypoxia remains unknown. Accumulating evidence suggests that hemoglobin (Hb) in RBCs may serve as an O2 sensor and O2-responsive NO signal transducer to regulate systemic and pulmonary vascular tone, but this remains unexamined at the integrated system level. One residue invariant in mammalian Hbs, β-globin cysteine93 (βCys93), carries NO as vasorelaxant S-nitrosothiol (SNO) to autoregulate blood flow during O2 delivery. βCys93Ala mutant mice thus exhibit systemic hypoxia despite transporting O2 normally. Here, we show that βCys93Ala mutant mice had reduced S-nitrosohemoglobin (SNO-Hb) at baseline and upon targeted SNO repletion and that hypoxic vasodilation by RBCs was impaired in vitro and in vivo, recapitulating hypoxic pathophysiology. Notably, βCys93Ala mutant mice showed marked impairment of hypoxic peripheral vasodilation and developed signs of pulmonary hypertension with age. Mutant mice also died prematurely with cor pulmonale (pulmonary hypertension with right ventricular dysfunction) when living under low O2. Altogether, we identify a major role for RBC SNO in clinically relevant vasodilatory responses attributed previously to endothelial NO. We conclude that SNO-Hb transduces the integrated, system-wide response to hypoxia in the mammalian respiratory cycle, expanding a core physiological principle.

Authors

Rongli Zhang, Alfred Hausladen, Zhaoxia Qian, Xudong Liao, Richard T. Premont, Jonathan S. Stamler

×

Figure 1

Reduction of SNO-Hb in Cys93A RBCs and impairment of hypoxic vasodilation.

Options: View larger image (or click on image) Download as PowerPoint
Reduction of SNO-Hb in Cys93A RBCs and impairment of hypoxic vasodilatio...
(A) SNO levels after treatment of RBCs from C93 control and C93A mice with CysNO (n = 10 for C93; n = 9 for C93A). (B) Baseline SNO in untreated RBCs from C93 and C93A mice (n = 14 each). (C) RBC-mediated hypoxic vasodilation of isolated aortic rings in vitro. SNO-loaded RBCs in A were added to bioassays under hypoxia (1% O2) or normoxia (20% O2) (n = 6 each). Data shown as mean ± SD. *P < 0.05, **P < 0.01 vs. C93, 2-tailed Student’s t test. (D) Representative aortic ring bioassay response to adding SNO-loaded C93 versus C93A RBCs (arrow) over time, in 1% O2 or 20% O2, normalized to 100% tension with phenylephrine. (E) Vasodilation in abdominal aorta in vivo at baseline and after aortic ligature release. Data shown as mean ± SEM. n = 11 C93 (4.0 ± 0.3 months); n = 10 C93A (3.7 ± 0.4 months). *P < 0.05 vs. C93, 2-way ANOVA. (F) Peak vasodilation of aorta, calculated from peak response from each mouse. Data shown as mean ± SD. *P < 0.05 vs. C93, 2-tailed Student’s t test. (G) Representative short axis M-mode images of abdominal aorta depicting aortic dilation (and impairment in C93A). Dashed lines represent vessel wall positions at diastole, for calculating diameter. Vertical scale bar: 2 mm; horizontal: 50 ms. (H) Mean blood flow increase after aortic ligature release. Data shown as mean ± SEM. n = 16 C93 (3.8 ± 0.9 months); n = 17 C93A (3.8 ± 0.7 months). *P < 0.05 vs. C93, 2-way ANOVA. (I) Peak flow increase, calculated from each mouse. Data shown as mean ± SD. *P < 0.05 vs. C93, 2-tailed Student’s t test. (J) Representative abdominal aortic blood flow curves.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts